USPTO Grants IGC Pharma Patent Covering IGC-AD1 for Novel Composition Targeting Alzheimer's Disease and Central Nervous System Disorders

POTOMAC, MARYLAND / ACCESS Newswire / November 13, 2025 / IGC Pharma, Inc. ("IGC Pharma," "IGC," or the "Company") (NYSE ...

VIZSLA COPPER ANNOUNCES THE ACQUISITION OF THE PALMER CRITICAL MINERALS VMS PROJECT IN ALASKA AND UP TO $25 MILLION NON-BROKERED PR…

Vizsla Copper Corp. (TSX.V: VCU, OTCQB: VCUFF) ("Vizsla Copper" or the "Company") is pleased to announce that it has entered ...